Related Experiment Videos
Total Synthesis of (+)-Sinefungin
1Department of Chemistry, University of Illinois at Chicago, 845 West Taylor Street, Chicago, Illinois 60607.
The Journal of Organic Chemistry
|September 6, 1996
Summary
This study details the asymmetric synthesis of sinefungin, a nucleoside antibiotic. Key stereocenters were established using diastereoselective allylation and rhodium-catalyzed hydrogenation, overcoming challenges in the final adenosylation step.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Antibiotic Synthesis
Background:
- Sinefungin is a nucleoside antibiotic with potential therapeutic applications.
- Previous synthesis routes may have limitations in stereochemical control or efficiency.
- The precise construction of stereocenters is crucial for biological activity.
Purpose of the Study:
- To develop an efficient asymmetric synthesis of sinefungin.
- To establish robust methods for constructing the C-6 and C-9 stereocenters.
- To overcome synthetic challenges in the final adenosylation step.
Main Methods:
- Asymmetric synthesis utilizing a diastereoselective allylation of an oxazolidinone derivative for C-6 stereochemistry.
- Curtius rearrangement to functionalize the C-6 position.
- Rhodium chiral bisphosphine-catalyzed asymmetric hydrogenation for C-9 amino acid stereochemistry.
- Vorbrüggen's protocol with persilylated N(6)-benzoyladenine for successful adenosylation.
Main Results:
- High diastereoselectivity (>99% de) achieved in the allylation step for C-6 amine stereochemistry.
- Efficient establishment of C-9 amino acid stereochemistry via asymmetric hydrogenation.
- Overcame difficulty in adenosylation by converting the C-6 urethane to an N-benzyl derivative.
- Successful sinefungin synthesis through optimized Vorbrüggen protocol.
Conclusions:
- A viable and efficient asymmetric synthesis of sinefungin has been developed.
- The synthetic strategy effectively controls key stereocenters (C-6 and C-9).
- The study provides a reliable method for constructing nucleoside analogs with potential pharmaceutical value.